Skip to main content

Table 1 Baseline patients’ characteristics

From: Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema

Baseline Characteristics

N (%)

Male

6 (50)

Female

6 (50)

Age (years)

 

˂60

60–65

> 65

7 (58.3)

4 (33.3)

1 (8.3)

Duration of DM (years)

 

˂10

10–15

> 15

2 (17)

6 (50)

4 (33.3)

BCVA (decimal)

 

˂0.1

0.1–0.5

> 0.5

2 (17)

9 (75)

1 (8.3)

IOP (mmHg)

 

˂15

15–20

> 20

1 (8.3)

10 (83.3)

1 (8.3)

CMT (µ)

 

< 400

400–600

> 600

3 (25)

5 (41.6)

4 (33.3)

Lens status

 

Phakic

• Clear lens

• Pre-existing sclerosis

Pseudophakic

10 (83.3)

7 (70)

3 (30)

2 (17)

  1. BCVA, best-corrected visual acuity; CMT, central macular thickness; DM, diabetes mellitus; IOP, intraocular pressure; µ, micron